ReviewRSC advances2026
The Staudinger reaction: a versatile synthetic tool for the construction of β-lactams, heterocycles, and functional organic molecules.
Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Staudinger reaction, first reported by Hermann Staudinger in 1907 as a ketene-imine [2+2] cycloaddition for the synthesis of β-lactams, has evolved into one of the most versatile transformations in modern organic synthesis. Beyond its classical applications in β-lactam formation and azide reduction to primary amines, the reaction now includes several advanced methodologies with broad applications in medicinal chemistry, chemical biology, and materials science. This review summarizes the evolution of the Staudinger reaction from its classical forms to recent developments, including metal-free microwave-assisted Wolff-Staudinger cascade reactions, continuous-flow multicomponent strategies, and ketene generation through toluenesulfonyl chloride (TsCl)-mediated activation. It also highlights the use of Staudinger-based methodologies, such as Staudinger-aza-Wittig, Ugi-Staudinger, and asymmetric catalytic sequences, for the efficient synthesis of five- and six-membered heterocycles, complex alkaloids, and chiral nitrogen-containing compounds. Particular emphasis is placed on compounds reported between 2020 and 2026, with a comparative evaluation of synthetic methodologies, reaction yields, stereochemical outcomes, and biological activities. The review further discusses the pharmaceutical significance of Staudinger-derived molecules, including β-lactam antibiotics that inhibit penicillin-binding proteins, as well as applications in glycobiology, biomolecular labeling, and cancer research. Collectively, these advances demonstrate the continued importance of the Staudinger reaction as a powerful and adaptable platform for the synthesis of biologically relevant molecules and advanced functional materials.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.